Mometasone furoato (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mometasone furoato" in Italian language version.

refsWebsite

Global rank Italian rank

13nih.gov

4^th place

9^th place

10doi.org

2^nd place

7^th place

6oadoi.org

799^th place

22^nd place

5archive.org

6^th place

8^th place

archive.org

ZR. Tayab, TC. Fardon; DK. Lee; K. Haggart; LC. McFarlane; BJ. Lipworth; G. Hochhaus, Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate., in Br J Clin Pharmacol, vol. 64, n. 5, novembre 2007, pp. 698-705, DOI:10.1111/j.1365-2125.2007.02919.x, PMID 17509041.
AS. Nayak, C. Banov; J. Corren; BK. Feinstein; A. Floreani; BF. Friedman; A. Goldsobel; GM. Gottschlich; PJ. Hannaway; KL. Lampl; RJ. Lapidus, Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma., in Ann Allergy Asthma Immunol, vol. 84, n. 4, aprile 2000, pp. 417-24, DOI:10.1016/S1081-1206(10)62275-2, PMID 10795650.
M. Noonan, JP. Karpel; GW. Bensch; JW. Ramsdell; DR. Webb; KB. Nolop; BN. Lutsky, Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler., in Ann Allergy Asthma Immunol, vol. 86, n. 1, gennaio 2001, pp. 36-43, DOI:10.1016/S1081-1206(10)62353-8, PMID 11206236.
JP. Kemp, RB. Berkowitz; SD. Miller; JJ. Murray; K. Nolop; JE. Harrison, Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma., in J Allergy Clin Immunol, vol. 106, n. 3, settembre 2000, pp. 485-92, DOI:10.1067/mai.2000.109431, PMID 10984368.
DI. Bernstein, RB. Berkowitz; P. Chervinsky; DJ. Dvorin; AF. Finn; GN. Gross; M. Karetzky; JP. Kemp; C. Laforce; W. Lumry; LM. Mendelson, Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler., in Respir Med, vol. 93, n. 9, settembre 1999, pp. 603-12, PMID 10542973.

doi.org

dx.doi.org

ZR. Tayab, TC. Fardon; DK. Lee; K. Haggart; LC. McFarlane; BJ. Lipworth; G. Hochhaus, Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate., in Br J Clin Pharmacol, vol. 64, n. 5, novembre 2007, pp. 698-705, DOI:10.1111/j.1365-2125.2007.02919.x, PMID 17509041.
M. Penagos, E. Compalati; F. Tarantini; CE. Baena-Cagnani; G. Passalacqua; GW. Canonica, Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials., in Allergy, vol. 63, n. 10, ottobre 2008, pp. 1280-91, DOI:10.1111/j.1398-9995.2008.01808.x, PMID 18721246.
V. Chur, CB. Small; P. Stryszak; A. Teper, Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children., in Pediatr Allergy Immunol, vol. 24, n. 1, febbraio 2013, pp. 33-8, DOI:10.1111/pai.12032, PMID 23331528.
P. Stjärne, K. Blomgren; P. Cayé-Thomasen; S. Salo; T. Søderstrøm, The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study., in Acta Otolaryngol, vol. 126, n. 6, giugno 2006, pp. 606-12, DOI:10.1080/00016480500452566, PMID 16720445.
P. Stjärne, R. Mösges; M. Jorissen; D. Passàli; L. Bellussi; H. Staudinger; M. Danzig, A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis., in Arch Otolaryngol Head Neck Surg, vol. 132, n. 2, febbraio 2006, pp. 179-85, DOI:10.1001/archotol.132.2.179.
TB. Fausnight, TJ. Craig, Mometasone furoate dry powder inhaler for the treatment of asthma., in Expert Opin Pharmacother, vol. 12, n. 17, dicembre 2011, pp. 2707-12, DOI:10.1517/14656566.2011.630390, PMID 22049912.
H. Milgrom, Mometasone furoate in children with mild to moderate persistent asthma: a review of the evidence., in Paediatr Drugs, vol. 12, n. 4, agosto 2010, pp. 213-21, DOI:10.2165/11316220-000000000-00000, PMID 20593906.
AS. Nayak, C. Banov; J. Corren; BK. Feinstein; A. Floreani; BF. Friedman; A. Goldsobel; GM. Gottschlich; PJ. Hannaway; KL. Lampl; RJ. Lapidus, Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma., in Ann Allergy Asthma Immunol, vol. 84, n. 4, aprile 2000, pp. 417-24, DOI:10.1016/S1081-1206(10)62275-2, PMID 10795650.
M. Noonan, JP. Karpel; GW. Bensch; JW. Ramsdell; DR. Webb; KB. Nolop; BN. Lutsky, Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler., in Ann Allergy Asthma Immunol, vol. 86, n. 1, gennaio 2001, pp. 36-43, DOI:10.1016/S1081-1206(10)62353-8, PMID 11206236.
JP. Kemp, RB. Berkowitz; SD. Miller; JJ. Murray; K. Nolop; JE. Harrison, Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma., in J Allergy Clin Immunol, vol. 106, n. 3, settembre 2000, pp. 485-92, DOI:10.1067/mai.2000.109431, PMID 10984368.

nih.gov

ncbi.nlm.nih.gov

ZR. Tayab, TC. Fardon; DK. Lee; K. Haggart; LC. McFarlane; BJ. Lipworth; G. Hochhaus, Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate., in Br J Clin Pharmacol, vol. 64, n. 5, novembre 2007, pp. 698-705, DOI:10.1111/j.1365-2125.2007.02919.x, PMID 17509041.
M. Penagos, E. Compalati; F. Tarantini; CE. Baena-Cagnani; G. Passalacqua; GW. Canonica, Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials., in Allergy, vol. 63, n. 10, ottobre 2008, pp. 1280-91, DOI:10.1111/j.1398-9995.2008.01808.x, PMID 18721246.
CM. Baldwin, LJ. Scott, Mometasone furoate: a review of its intranasal use in allergic rhinitis., in Drugs, vol. 68, n. 12, 2008, pp. 1723-39, PMID 18681494.
V. Chur, CB. Small; P. Stryszak; A. Teper, Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children., in Pediatr Allergy Immunol, vol. 24, n. 1, febbraio 2013, pp. 33-8, DOI:10.1111/pai.12032, PMID 23331528.
P. Stjärne, K. Blomgren; P. Cayé-Thomasen; S. Salo; T. Søderstrøm, The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study., in Acta Otolaryngol, vol. 126, n. 6, giugno 2006, pp. 606-12, DOI:10.1080/00016480500452566, PMID 16720445.
RA. Tan, J. Corren, Mometasone furoate in the management of asthma: a review., in Ther Clin Risk Manag, vol. 4, n. 6, Dic 2008, pp. 1201-8, PMID 19337427.
TB. Fausnight, TJ. Craig, Mometasone furoate dry powder inhaler for the treatment of asthma., in Expert Opin Pharmacother, vol. 12, n. 17, dicembre 2011, pp. 2707-12, DOI:10.1517/14656566.2011.630390, PMID 22049912.
H. Milgrom, Mometasone furoate in children with mild to moderate persistent asthma: a review of the evidence., in Paediatr Drugs, vol. 12, n. 4, agosto 2010, pp. 213-21, DOI:10.2165/11316220-000000000-00000, PMID 20593906.
M. Sharpe, B. Jarvis, Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma., in Drugs, vol. 61, n. 9, 2001, pp. 1325-50, PMID 11511026.
AS. Nayak, C. Banov; J. Corren; BK. Feinstein; A. Floreani; BF. Friedman; A. Goldsobel; GM. Gottschlich; PJ. Hannaway; KL. Lampl; RJ. Lapidus, Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma., in Ann Allergy Asthma Immunol, vol. 84, n. 4, aprile 2000, pp. 417-24, DOI:10.1016/S1081-1206(10)62275-2, PMID 10795650.
M. Noonan, JP. Karpel; GW. Bensch; JW. Ramsdell; DR. Webb; KB. Nolop; BN. Lutsky, Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler., in Ann Allergy Asthma Immunol, vol. 86, n. 1, gennaio 2001, pp. 36-43, DOI:10.1016/S1081-1206(10)62353-8, PMID 11206236.
JP. Kemp, RB. Berkowitz; SD. Miller; JJ. Murray; K. Nolop; JE. Harrison, Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma., in J Allergy Clin Immunol, vol. 106, n. 3, settembre 2000, pp. 485-92, DOI:10.1067/mai.2000.109431, PMID 10984368.
DI. Bernstein, RB. Berkowitz; P. Chervinsky; DJ. Dvorin; AF. Finn; GN. Gross; M. Karetzky; JP. Kemp; C. Laforce; W. Lumry; LM. Mendelson, Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler., in Respir Med, vol. 93, n. 9, settembre 1999, pp. 603-12, PMID 10542973.

oadoi.org

M. Penagos, E. Compalati; F. Tarantini; CE. Baena-Cagnani; G. Passalacqua; GW. Canonica, Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials., in Allergy, vol. 63, n. 10, ottobre 2008, pp. 1280-91, DOI:10.1111/j.1398-9995.2008.01808.x, PMID 18721246.
V. Chur, CB. Small; P. Stryszak; A. Teper, Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children., in Pediatr Allergy Immunol, vol. 24, n. 1, febbraio 2013, pp. 33-8, DOI:10.1111/pai.12032, PMID 23331528.
P. Stjärne, K. Blomgren; P. Cayé-Thomasen; S. Salo; T. Søderstrøm, The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study., in Acta Otolaryngol, vol. 126, n. 6, giugno 2006, pp. 606-12, DOI:10.1080/00016480500452566, PMID 16720445.
P. Stjärne, R. Mösges; M. Jorissen; D. Passàli; L. Bellussi; H. Staudinger; M. Danzig, A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis., in Arch Otolaryngol Head Neck Surg, vol. 132, n. 2, febbraio 2006, pp. 179-85, DOI:10.1001/archotol.132.2.179.
TB. Fausnight, TJ. Craig, Mometasone furoate dry powder inhaler for the treatment of asthma., in Expert Opin Pharmacother, vol. 12, n. 17, dicembre 2011, pp. 2707-12, DOI:10.1517/14656566.2011.630390, PMID 22049912.
H. Milgrom, Mometasone furoate in children with mild to moderate persistent asthma: a review of the evidence., in Paediatr Drugs, vol. 12, n. 4, agosto 2010, pp. 213-21, DOI:10.2165/11316220-000000000-00000, PMID 20593906.